AASM Sleep Medicine Disruptors: Innovation Driving the Future of Sleep Care
The field of sleep medicine is rapidly evolving, and innovation is at the center of that transformation. The American Academy of Sleep Medicine (AASM) continues to spotlight this progress through its Sleep Medicine Disruptors Innovation Award—recognizing technologies that are reshaping how sleep disorders are diagnosed and managed.
Read more about the award winners here:
https://aasm.org/aasm-sleep-medicine-disruptors-innovation-award-winners/
As highlighted by AASM, the next generation of sleep solutions is focused on improving access, increasing diagnostic accuracy, and reducing the burden on both patients and providers.
For sleep clinics and program directors, this shift reflects a growing need for tools that can:
- Expand diagnostic capacity without adding staff
- Reduce reliance on a single testing pathway
- Improve confidence in diagnosing complex, multi-disorder patients
The traditional gap between in-lab polysomnography (PSG) and home sleep testing continues to create bottlenecks in care delivery. New technologies are emerging to bridge that gap—bringing clinical-grade insights into more scalable, patient-friendly environments.
Dormotech is part of this movement, focused on enabling more flexible, comprehensive sleep diagnostics that align with how modern sleep programs need to operate. As the industry evolves, the emphasis is no longer just on testing—but on delivering the right test for the right patient at the right time, without compromising clinical integrity.
DormoVision X™ delivers automated, AI-supported analysis with multi-night data capture, enabling more accurate and confident clinical decisions. Designed to integrate into existing workflows, the platform helps sleep programs expand diagnostic capacity without increasing staff burden—supporting higher-quality care at scale.
If your organization is evaluating how to expand diagnostic reach without defaulting every patient to either traditional in-lab PSG or limited-channel home testing alone, Dormotech is worth a closer look.
For further information about Dormotech, please contact:
Abed Nassir, CEO (abed@dormotech.com)
Kyle Hunter, CCO (kyle@dormotech.com)
Featured Articles
Clinical Validations
April 18, 2026
Patient Report: The Effects of Continuous Positive Airway Pressure (CPAP) Therapy on Sleep Quality, Particularly Deep Sleep and Arousals Saar Lanir, PhD, Neuroscientist and sleep researcher at Dormotech Medical. Introduction Sleep-related breathing disorders (SRBDs), including obstructive sleep apnea (OSA), are highly prevalent and associated with substantial morbidity (1). The American Academy of Sleep Medicine […]
View
Research
March 31, 2026
Pediatric sleep disorders, especially sleep apnea, are often underdiagnosed, yet they can have a significant impact on a child’s development, behavior, and long-term health. In a recent article featuring insights from Dr. Asher Tal, the importance of early detection and proper diagnostic pathways is brought into sharp focus. Read the full article here: https://sleepworldmagazine.com/2025/07/28/dormotech-need-for-early-pediatric-sleep-apnea/ One […]
View
Clinical Validations
March 31, 2026
Pediatric sleep disorders are more common—and more complex—than many realize. From sleep apnea to behavioral sleep issues, early identification is critical to ensuring proper development, cognitive function, and overall health in children. In this short video, we walk through how sleep disorders present in pediatric patients, what signs to look for, and why proper testing […]
View